用于格雷夫斯甲亢的阻断-替代与滴定抗甲状腺药物治疗方案：二并不总是优于一。 - Suppr

Block-and-replace vs. titration antithyroid drug regimen for Graves' hyperthyroidism: two is not always better than one.

作者信息

Duntas L H

机构信息

Evgenideion Hospital, Unit of Endocrinology, Diabetes and Metabolism, Thyroid Section, University of Athens, 20 Papadiamantopoulou Str, 11528, Athens, Greece.

出版信息

J Endocrinol Invest. 2021 Jun;44(6):1337-1339. doi: 10.1007/s40618-020-01431-1. Epub 2020 Sep 30.

DOI:10.1007/s40618-020-01431-1

PMID:33000387

Abstract

摘要

相似文献

Block-and-replace vs. titration antithyroid drug regimen for Graves' hyperthyroidism: two is not always better than one.

J Endocrinol Invest. 2021 Jun;44(6):1337-1339. doi: 10.1007/s40618-020-01431-1. Epub 2020 Sep 30.

Antithyroid drug regimen for treating Graves' hyperthyroidism.

Cochrane Database Syst Rev. 2005 Apr 18(2):CD003420. doi: 10.1002/14651858.CD003420.pub3.

Antithyroid drug regimen for treating Graves' hyperthyroidism.

Cochrane Database Syst Rev. 2004(2):CD003420. doi: 10.1002/14651858.CD003420.pub2.

Antithyroid drug regimen for treating Graves' hyperthyroidism.

Cochrane Database Syst Rev. 2003(4):CD003420. doi: 10.1002/14651858.CD003420.

Antithyroid drug regimen for treating Graves' hyperthyroidism.

Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD003420. doi: 10.1002/14651858.CD003420.pub4.

Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.

J Endocrinol Invest. 2021 Feb;44(2):371-378. doi: 10.1007/s40618-020-01320-7. Epub 2020 Jun 10.

Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.

J Med Case Rep. 2017 Feb 6;11(1):32. doi: 10.1186/s13256-017-1214-6.

The role of laboratory medicine in the diagnosis of the hyperthyroidism.

Q J Nucl Med Mol Imaging. 2021 Jun;65(2):91-101. doi: 10.23736/S1824-4785.21.03344-6. Epub 2021 Feb 10.

Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.

N Engl J Med. 1991 Apr 4;324(14):947-53. doi: 10.1056/NEJM199104043241403.

Preserved activation of thyrotropin receptor antibody to stimulate thyroid function despite long-term treatment in euthyroid patients with Graves' disease.

Eur J Endocrinol. 1998 Mar;138(3):281-5. doi: 10.1530/eje.0.1380281.

引用本文的文献

High-dose versus low-dose block-and-replace treatment for a first episode of Graves' disease.

Eur Thyroid J. 2025 Apr 14;14(2). doi: 10.1530/ETJ-25-0039. Print 2025 Apr 1.

COVID-19 and Thyroid Diseases: A Bidirectional Impact.

J Endocr Soc. 2021 Apr 27;5(8):bvab076. doi: 10.1210/jendso/bvab076. eCollection 2021 Aug 1.

本文引用的文献

Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.

J Endocrinol Invest. 2021 Feb;44(2):371-378. doi: 10.1007/s40618-020-01320-7. Epub 2020 Jun 10.

Current controversies in the management of Graves' hyperthyroidism.

Expert Rev Endocrinol Metab. 2020 May;15(3):159-169. doi: 10.1080/17446651.2020.1754192. Epub 2020 Apr 21.

"Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.

J Endocrinol Invest. 2020 May;43(5):595-600. doi: 10.1007/s40618-019-01144-0. Epub 2019 Nov 12.

ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years later.

Eur J Endocrinol. 2018 Oct 12;179(5):R261-R274. doi: 10.1530/EJE-18-0678.

Block & replace regime versus titration regime of antithyroid drugs for the treatment of Graves' disease: a retrospective observational study.

Clin Endocrinol (Oxf). 2014 Oct;81(4):610-3. doi: 10.1111/cen.12478. Epub 2014 May 19.

Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.

Thyroid. 2011 Sep;21(9):951-6. doi: 10.1089/thy.2011.0039. Epub 2011 Aug 11.

Antithyroid drugs.

N Engl J Med. 2005 Mar 3;352(9):905-17. doi: 10.1056/NEJMra042972.

Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease.

Thyroid. 2000 Jul;10(7):527-32. doi: 10.1089/thy.2000.10.527.

Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.

N Engl J Med. 1996 Jan 25;334(4):220-4. doi: 10.1056/NEJM199601253340403.

Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose.

Eur J Endocrinol. 1994 Aug;131(2):120-4. doi: 10.1530/eje.0.1310120.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Block-and-replace vs. titration antithyroid drug regimen for Graves' hyperthyroidism: two is not always better than one.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献